JOHN E WAGNER
Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology MINNEAPOLIS, MN NPI 1205933595
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology MN Chugai Pharmaceutical Co., Ltd. All categories
General Payments — all program years on this page
$54,534.70
- Category: General Payments
- Program years: PY2021–2024
- Record count: 18
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $28,393.12 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $14,456.67 | 3 |
| Travel and Lodging | $13,936.45 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Chugai Pharmaceutical Co., Ltd. | $19,055.32 | 4 |
| VERTEX PHARMACEUTICALS INCORPORATED | $9,337.80 | 3 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1105905571 | VERTEX PHARMACEUTICALS INCORPORATED | $4,620.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1105909762 | VERTEX PHARMACEUTICALS INCORPORATED | $4,200.00 | 03/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1105923539 | VERTEX PHARMACEUTICALS INCORPORATED | $517.80 | 11/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1133036478 | Chugai Pharmaceutical Co., Ltd. | $12,854.59 | 03/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1133036482 | Chugai Pharmaceutical Co., Ltd. | $51.72 | 03/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1133036486 | Chugai Pharmaceutical Co., Ltd. | $512.34 | 03/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1133036490 | Chugai Pharmaceutical Co., Ltd. | $5,636.67 | 03/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.